Showing results (441-450 of 3,032) with videos related to
Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|November 21, 2019
How safe are our studies? Analysis of adverse events in Bayer First-in-Human trials from 2006 to 2016David Jung, Michael-Friedrich Boettcher, Georg WensingInternational Journal of Clinical Pharmacology and Therapeutics|December 18, 2019
A UPLC-MS/MS method for quantification of perindopril and perindoprilat and applied in a bioequivalence study for their pharmacokinetic parameter measurementYuxiu Gu, Hualin Cai, Jianjun Guo, et al.International Journal of Clinical Pharmacology and Therapeutics|December 20, 2019
Influence of co-initiation of antiulcer drugs on persistence and adherence to low-dose aspirin: A retrospective cohort study using a Japanese claims databaseMakiko Iwasawa, Keiko Sagami, Satoshi Yokoyama, et al.International Journal of Clinical Pharmacology and Therapeutics|March 9, 2020
Clozapine-induced anemia: A case-reportGeorgios Eleftheriou, Raffaella Butera, Luca Barcella, et al.International Journal of Clinical Pharmacology and Therapeutics|February 2, 2019
Cardiac toxicity of combined vemurafenib and cobimetinib administrationRoberto Fiocchi, Mauro Gori, Filippo Taddei, et al.International Journal of Clinical Pharmacology and Therapeutics|February 14, 2020
Genetic polymorphism in MDR1 C3435T is a determinant of methotrexate cerebrospinal fluid concentrations in Chinese children with acute lymphoblastic leukemiaYu-Xin Zhang, Yu Ma, Hao Zhang, et al.International Journal of Clinical Pharmacology and Therapeutics|February 11, 2019
Comparison of N-glycans expressed in tumor tissues with those expressed in adjacent non-tumor tissues of colorectal cancer patientsEunhee JiInternational Journal of Clinical Pharmacology and Therapeutics|January 22, 2019
A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjectsHong Zhang, Xiaoxue Zhu, Haijing Wei, et al.International Journal of Clinical Pharmacology and Therapeutics|January 22, 2019
Multiple severe vertebral fractures during the 3-month period following a missed dose of denosumab in a postmenopausal woman with osteoporosis previously treated with alendronateFrancisco Bandeira, Gustavo Torres, Elba Bandeira, et al.International Journal of Clinical Pharmacology and Therapeutics|January 22, 2019
Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndromeXiaoqing Wang, Ye Han, Chaoyang Chen, et al.Pageof 304